Mild postoperative acute kidney injury and outcomes after surgery for congenital heart disease  by Taylor, Marnie L. et al.
Congenital Heart Disease Taylor et al
C
H
DMild postoperative acute kidney injury and outcomes after surgery
for congenital heart diseaseMarnie L. Taylor, MD,a Fabio Carmona, MD,a Ravi R. Thiagarajan, MBBS, MPH,a,d LaurenWestgate, RN,













146Objective: The effect of mild acute kidney injury (AKI) on outcomes after heart surgery in children is unclear.
We sought to characterize the epidemiology of mild AKI associated with surgery for congenital heart disease
(CHS-AKI) in children.
Methods:We conducted a single-center, retrospective cohort study of 693 patients (aged 6 days-18 years) who
underwent heart surgery in 2009. The prevalence of AKI within 72 hours of surgery was determined using the
3-stage Acute Kidney Injury Network criteria. Factors associated with both hospital length of stay and AKI were
used in a proportional hazards model to test the association of stage 1 AKI with hospital length of stay.
Results: The median age of the patients was 11.5 months (interquartile range, 3-54 months). Eighteen percent of
the cohort had single ventricle heart disease and 54% underwent RACHS-1 category 3 or higher surgery. The
prevalence of stages 1, 2, and 3 AKI in this cohort was 11% (n¼ 77), 3% (n¼ 19), and 1% (n¼ 8), respectively.
Factors independently associated with AKI were prematurity, single ventricle physiology, peak postoperative
lactic acid concentration, cardiopulmonary bypass time, and a history of heart surgery. Stage 2 or greater
CHS-AKI was associated with hospital length of stay (adjusted hazard ratio [AHR], 0.53; 95% confidence in-
terval [CI], 0.33-0.87; P ¼ .01), but stage 1 was not (AHR, 0.85; 95% CI, 0.66-1.10; P ¼ .22).
Conclusions: AKI occurs after surgery for congenital heart disease but may be less common than previously
reported. Although moderate to severe CHS-AKI is independently associated with prolonged recovery after
heart surgery, mild disease does not appear to be. (J Thorac Cardiovasc Surg 2013;146:146-52)Data suggesting adverse clinical outcomes for heteroge-
neous populations of critically ill patients with acute kidney
injury (AKI) are accumulating.1-4 Mild AKI after cardiac
surgery in adults (a serum creatinine increase of 0.3
mg/dL from baseline) occurs in up to 30% of patients and
is associated with increased rates of morbidity and
mortality, increased health care resource utilization, and
longer lengths of stay in the hospital.5-7 The few
epidemiologic studies of AKI in children undergoing
surgery for congenital heart disease report an association
with adverse outcomes and an overall prevalence of 36%
to 52%, the majority (57%-61%) of which is limited to
mild disease. These studies were limited by sample sizes
that precluded assessment of the effects of mild AKI on
outcomes and, in some instances, suboptimal control for
potentially important confounders of this complex
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The Journal of Thoracic and Cardiovascular Surgfrom the few available epidemiologic studies of AKI
associated with surgery for congenital heart disease
(CHS-AKI) in children, investigators have begun to
propose and conduct a variety of prospective trials
targeting the amelioration of CHS-AKI with the hope of im-
proving outcomes.12-14 Given the paucity of existing data,
the limitations of the previous studies, and the
accelerating interest in attempting to decrease the
frequency and severity of CHS-AKI, we undertook this
study for 4 principal reasons: (1) to determine the preva-
lence and severity of CHS-AKI, (2) to determine which fac-
tors are associated with the development of CHS-AKI, (3)
to determine whether mild AKI is associated with adverse
clinical outcomes, and (4) to determine what proportion
of patients with CHS-AKI have renal dysfunction at the
time of hospital discharge. We hypothesized that mild
CHS-AKI would not be associated with prolonged recovery
from heart surgery after controlling for confounders.
MATERIALS AND METHODS
Setting and Patients
This retrospective cohort study was conducted in the 29-bed Cardiac In-
tensive Care Unit at Children’s Hospital Boston. We included all patients
who (1) underwent Risk Adjustment for Congenital Heart Surgery-1
(RACHS-1)15 classifiable cardiac surgery at our institution during the
2009 calendar year, (2) were more than 5 days of age and less than 18 years
of age on the day of surgery, and (3) were free of renal replacement therapy
at the time of surgery. For patients who underwent more than 1 operation
during the study period, each operative procedurewas handled as a separateery c July 2013
Abbreviations and Acronyms
AHR ¼ adjusted hazard ratio
AKI ¼ acute kidney injury
AKIN ¼ Acute Kidney Injury Network
CHS-AKI ¼ acute kidney injury associated with
surgery for congenital heart disease
CI ¼ confidence interval
pRIFLE ¼ pediatric modification of RIFLE
classification system
RACHS-1 ¼ Risk Adjustment for Congenital Heart
Surgery-1
RIFLE ¼ risk, injury, failure, loss of kidney
function, and end-stage renal failure
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Devent provided the patient was discharged home between operations. The
Committee on Clinical Investigation at Children’s Hospital Boston ap-
proved the study and waived the requirement for written informed consent.
Definition of Variables and Outcomes
The primary predictor variable for the study was the degree of AKI, de-
fined using the Acute Kidney Injury Network’s (AKIN) 3-tiered staging
system.16 The definitions of the 3 stages of AKI in the in AKIN classifica-
tion are as follows: stage 1, increase in plasma creatinine of 0.3 mg/dL
or increase in plasma creatinine to 150% to 200% (>1.5-fold to
2-fold increase) of baseline; stage 2, increase in plasma creatinine to
200% to 300% (>2-fold to 3-fold) of baseline; stage 3, increase in plasma
creatinine to more than 300% (>3-fold) of baseline (with a rise of at least
0.5 mg/dL), or a postoperative plasma creatinine concentration 4.0 mg/
dL, or need for postoperative renal replacement therapy. Stages 2 and 3
AKI were grouped together a priori inasmuch as the prevalence of stage
3 AKI is low in our institution. Recognizing the error inherent in creatinine
measurements and the low creatinine concentrations in most children, we
required a minimum increase in plasma creatinine of 0.2mg/dL to meet cri-
teria for AKI. Justifying this cutoff, the coefficient of variation for the
Roche mass spectroscopy–traceable enzymatic creatinine assay performed
in the Children’s Hospital Boston chemistry laboratory is 1.77%.
Given the lack of consensus regarding the most appropriate definition
of AKI in children, the pediatric modification of the RIFLE classification
system (risk, injury, failure, loss of kidney function, and end-stage renal
failure) was also used to categorize patients into 1 of the 4 pRIFLE AKI
stages; none, risk, injury, or failure.10 The primary difference between
the AKIN and pRIFLE staging systems is the use of a change in estimated
creatinine clearance to categorize patients in the latter, whereas the former
relies solely on the fold change in creatinine concentration. This definition
difference results in a greater number of children being categorized as hav-
ing mild AKI (risk) in the pRIFLE staging system than in the AKIN
system.17
Blood for the creatinine recorded as the ‘‘baseline’’ value was drawn
within 5 days of surgery. Each patient’s daily morning creatinine value
was recorded for postoperative days 0 to 3. The creatinine value obtained
closest to hospital discharge, if outside the 72-hour postoperative window,
was recorded as the ‘‘discharge creatinine.’’ The updated Schwartz for-
mula (0.413 $ length [cm]/creatinine [mg/dL]) was used to calculate the
estimated creatinine clearance.18 The following cutoffs (corresponding
to 50% of normal mean glomerular filtration rate for age) were used to
determine the presence or absence of renal dysfunction before surgery
and at the time of discharge: 6 to 13 days of age (21 mL $ min1 $
1.73 m2), 14 to 55 days of age (33 mL $ min1 $ 1.73 m2), 56 days toThe Journal of Thoracic and Ca2 years of age (48 mL $ min1 $ 1.73 m2), and 2 to 18 years of age
(60 mL $ min1 $ 1.73 m2).19
Health care–associated infections, defined using definitions put forth by
the Centers for Disease Control, included ventilator-associated pneumonia,
endotracheal tube– associated tracheitis, urinary tract infection, catheter-
associated bloodstream infections, and superficial and deep sternal wound
infections. Infants less than 3months of age at the time of surgery were cat-
egorized as premature if they were born at less than 38 weeks’ gestation.
Central nervous system injury was defined as seizure activity (electro-
graphic or clinical) or radiologic evidence of ischemia and/or hemorrhage
by ultrasound, computed tomography, and/or magnetic resonance imaging.
Congenital anomalies included syndromes, known disease causing chro-
mosomal abnormalities, and/or major noncardiac structural defects
(eg, cleft palate, solitary kidney, esophageal atresia, and so on); minor
structural defects were not included (eg, skin tags, superficial sacral dim-
ple). Preoperative mechanical ventilationwas defined as the need for a pe-
riod of mechanical ventilation during the same hospitalization, but before
surgery. Patients categorized as having single ventricle physiology in-
cluded all patients whose anatomy precluded biventricular repair at the
time of surgery.Necrotizing enterocolitiswas diagnosed by either the inten-
sive care unit attending physician or a general surgery consultant using
clinical judgment and radiography.Diaphragm paresis or paralysiswas di-
agnosed by ultrasound and/or fluoroscopy. Chylothorax was deemed to be
present by pleural fluid analysis and a switch to a low-fat formula. Heart
block was defined as documented atrioventricular node disturbance neces-
sitating temporary or permanent ventricular pacing. Arrhythmia was de-
fined as the presence of any abnormal rhythm necessitating intervention
(pharmacologic and/or pacing). Noninvasive ventilation techniques in-
cluded bilevel positive airway pressure, continuous positive airway pres-
sure, and/or high-flow nasal cannula.
Unintended reexploration was defined as any procedure intended to
control bleeding and/or relieve tamponade. Repeat surgery was defined
as any unintended cardiac surgery, including shunt manipulation but ex-
cluding delayed sternal closure and reexploration. Designation as a planned
or emergency surgery (eg, repair of obstructed total anomalous pulmonary
venous drainage) was made by the attending cardiothoracic surgeon at the
time of surgery. Cachexia and obesity were defined as a weight-for-age
Z-score at the time of surgery of 2 or less or more than 2, respectively.
Preoperative polycythemia and anemia were defined by hemoglobin con-
centrations outside the normal range for age. Peak lactate was the highest
postoperative lactate within 24 hours of surgery. Each index surgery was
assigned a RACHS-1 category. For patients who underwent more than 1
discrete surgical intervention during the same operation (eg, mitral valvu-
loplasty and subaortic membrane resection), the highest RACHS-1 cate-
gory among the individual components was assigned to the procedure.
The primary outcome variable was postoperative hospital length of stay.
Patients who died before hospital discharge were included in the nonpara-
metric analyses by assigning their hospital length of stay to the maximal
value for those surviving to discharge. When patients had more than 1 car-
diac surgical procedure during the same hospitalization, the day of the first
operation was used to calculate all postoperative length of stay parameters.Statistical Analysis
Predictive Analytics Software version 18.0.0 (SPSS, Inc, Chicago, Ill)
and Stata 11 (StataCorp, College Station, Tex) were used for statistical
analysis. Data are reported as frequency (n) with proportion (percent) or
medianvaluewith interquartile range (25th-75th percentile). TheWilcoxon
rank sum and Kruskal-Wallis tests were used to test the statistical signifi-
cance of continuous data. The c2 test and the c2 test for trend were used
to test the statistical significance of categorical data, and Fisher’s exact
test was used when more than 20% of the cells had expected counts of
less than 5. Multivariable logistic regression was used to identify preoper-
ative, intraoperative, and early postoperative factors associated with AKI
using covariates with a P value of .1 or less on bivariate statistical testing.rdiovascular Surgery c Volume 146, Number 1 147
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DGiven the anticipated low prevalence of severe AKI in this cohort, we made
the a priori decision to group moderate and severe AKI (stages 2 and 3) to-
gether for statistical analysis. To maintain model stability, we added the
RACHS-1 category into the logistic regression model as a dichotomous
variable (RACHS-1 category 3 and RACHS-1 category<3), dividing the
cohort into roughly equal-size groups.
Factors associated with AKI and hospital length of stay were identified
by bivariate analyses and subsequently included in a Cox proportional haz-
ards regression model of the primary outcome if the P value was .1 or less.
No selection procedure was used for entry of the candidate variables into
the models. The proportional hazards modeling was repeated after
substituting the pRIFLE AKI stages for the AKINAKI stages to determine
whether the effect of AKI on outcomes differed by AKI staging system.
The criterion for variable inclusion in the final models was set at P 
.05. Candidate variables in the Cox proportional hazards model were as-
sessed for time dependency by assessing whether log minus log survival
plots were parallel. Given that the number of postoperative days to hospital
discharge (ie, postoperative hospital length of stay) was the primary out-
come modeled, a hazard ratio of less than 1 signifies a lower instantaneous
risk of hospital discharge at any given time point or, more intuitively,
a greater risk of remaining hospitalized.RESULTS
Study Population, Change in Plasma Creatinine
Concentration, and Prevalence of AKI
The initial study cohort comprised 721 patients. Twenty-
eight patients were subsequently excluded (missing base-
line creatinine [n ¼ 18], preoperative extracorporeal
membrane oxygenation [n ¼ 1], and extracorporeal mem-
brane oxygenation within 72 hours of surgery [n¼ 9]), leav-
ing 693 patients representing the primary study cohort. The
median age of the children in the study at the time of surgery
was 11.5 months (interquartile range, 3.2-54 months). Of
these children, 18% (n¼ 121) had single ventricle heart dis-
ease, 42% (n ¼ 289) had previously undergone surgery for
congenital heart disease, 35% (n ¼ 240) were admitted to
the hospital before surgery, and 12% (n ¼ 82) were sup-
ported with a ventilator in the period before their index heart
surgery. The distribution of the operations performed in this
series by RACHS-1 categories 1 to 6 was as follows: 10%
(n ¼ 67), 37% (n ¼ 257), 40% (n ¼ 276), 11% (n ¼ 75),
0% (n ¼ 0), and 3% (n ¼ 18), respectively (Table 1). Ten
patients (1.4%) had renal dysfunction before surgery (an es-
timated creatinine clearance of  50% predicted for age),
the etiology of which was not documented. Criteria for
stages 1 (mild), 2 (moderate), and 3 (severe) AKI were
met within 72 hours of surgery in 11% (n ¼ 77), 3%
(n ¼ 19), and 1% (n ¼ 8) of the 693 patients, respectively,
for an overall prevalence of 15%. Absolute plasma creati-
nine concentrations stratified by age and development of
AKI are presented in Table 2. Six patients required renal re-
placement therapy in the postoperative period (1%), but
none was within the 72-hour postoperative window.Factors Associated With the Development of AKI
Important preoperative, intraoperative, and early
postoperative factors were tested for an association with148 The Journal of Thoracic and Cardiovascular SurgAKI (Table 1). There was no detectable difference in pre-
operative renal function between those in whom AKI
developed and those in whom it did not develop. Multivari-
able logistic regression modeling of AKI after cardiac
surgery demonstrated independent associations with
prematurity, single ventricle physiology, peak 24-hour
postoperative lactic acid concentration, duration of cardio-
pulmonary bypass, and history of heart surgery, but not
with higher RACHS-1 category, presence of residual heart
lesions (evidenced by need for postoperative surgical or
catheter-based reintervention), need for delayed sternal
closure, nor presence of preoperative polycythemia
(Table 3).
Outcomes of Patients With Postoperative AKI
Postoperative AKI, particularly stage 2 or 3 disease, was
associated with increased postoperative morbidity and
mortality on univariate analysis (Table 1). Those with
postoperative AKI were more likely to die after surgery
and had longer intensive care unit and hospital lengths
of stay than those without AKI. As shown in Table 4, mul-
tivariable proportional hazards modeling demonstrated
that whereas moderate to severe AKI (stages 2 and 3)
was independently associated with hospital length of
stay (adjusted hazard ratio [AHR], 0.53; 95% confidence
intervals [CI], 0.33-0.87; P ¼ .01), mild AKI (stage 1)
was not (AHR, 0.85; 95% CI, 0.66-1.10; P ¼ .22). The
same relationships of AKI stage to length of stay were
maintained after substituting the pRIFLE stage for
AKIN stage; risk level AKI (AHR, 1.01; 95% CI,
0.84-1.23; P ¼ .88) and injury and failure level AKI
(AHR, 0.60; 95% CI, 0.37-0.98; P ¼ .04). With respect
to renal outcomes, children who had AKI develop in the
early postoperative period were more likely to require
a limited period of renal replacement therapy in
the postoperative period than those who did not (4% vs
0.3%; P ¼ .006) but were no more likely to be discharged
with renal dysfunction (2% vs 1%; P ¼ .3).
DISCUSSION
In this study, we found a 15% prevalence of CHS-AKI in
a single-center cohort of nearly 700 infants, children, and
young adults who underwent a wide variety of cardiac sur-
gical procedures. The majority of patients in whomAKI de-
veloped (74%) were limited to mild disease (stage 1), while
18% and 8%, respectively, met stage 2 and 3 criteria. Mul-
tivariable modeling demonstrated that prematurity, single
ventricle physiology, a history of cardiac surgery, peak post-
operative lactic acid concentration, and duration of cardio-
pulmonary bypass were associated with the development of
CHS-AKI, whereas residual heart disease and higher
RACHS-1 category were not. After controlling for a variety
of potential confounders, children with more severe
CHS-AKI (stage 2 or 3) were 35% more likely to remainery c July 2013
TABLE 1. Perioperative characteristics and outcomes of the study cohort
No AKI (n ¼ 589) Stage 1 AKI (n ¼ 77) Stages 2 and 3 AKI (n ¼ 27) P value
Preoperative variables
Age at surgery (mo) 11.4 (3.3-58.3) 12.3 (3.0-44.6) 9.0 (3.0-30.8) .50
Length at surgery (cm)* 73 (59-104) 74 (57-94) 68 (56-87) .38
Weight at surgery (kg) 8.3 (4.72-17.5) 8.8 (4.4-13.7) 7.8 (3.7-12.6) .39
Gender (female) 282 (48) 35 (46) 9 (33) .32
Premature birth 28 (5) 9 (12) 2 (7) .04
Preoperative mechanical ventilation 66 (11) 10 (13) 6 (22) .21
Preoperative hospital admission 199 (34) 30 (39) 11 (41) .53
Single ventricle physiology 83 (14) 25 (33) 13 (48) <.001
Previous heart surgery 227 (39) 44 (57) 18 (67) <.001
Genetic syndrome 143 (24) 20 (26) 3 (11) .27
Cachectic 154 (26) 23 (30) 7 (26) .78
Obesity 7 (1) 0 (0) 1 (4) .30
Anemia 59 (10) 10 (13) 1 (4) .38
Polycythemia 223 (38) 40 (52) 18 (67) .001
Creatinine (mg/dL) 0.3 (0.3-0.4) 0.3 (0.3-0.4) 0.3 (0.2-0.4) .14
Estimated creatinine clearance (mL $ min1 $ 1.73 m2)* 107 (80-131) 97 (73-128) 128 (81-169) .18
Kidney disease* 8 (1) 1 (1) 1 (4) .64
Operative variables
RACHS-1 category <.001
1 67 (11) 0 (0) 0 (0)
2 232 (39) 21 (27) 4 (15)
3 218 (37) 45 (58) 13 (48)
4 59 (10) 8 (10) 8 (30)
6 13 (2) 3 (4) 2 (7)
Emergency surgery 6 (1) 1 (1) 1 (4) .44
Planned surgery 575 (98) 74 (96) 26 (96) .69
CPB time (min) 91 (60-131) 128 (88-173) 138 (92-227) <.001
Aortic crossclamp time (min) 54 (25-76) 75 (33-101) 64 (0-118) .003
Delayed sternal closure 50 (9) 15 (20) 10 (37) <.001
Circulatory arrest used 64 (11) 7 (9) 3 (11) .89
Postoperative variables
Peak lactate (mmol/L) 2.1 (1.6-2.9) 3.2 (2.1-4.7) 5.7 (3.9-7.5) <.001
Heart block requiring temporary pacing 23 (4) 11 (14) 3 (11) <.001
Arrhythmia 86 (15) 22 (29) 13 (48) <.001
Necrotizing enterocolitis 6 (1) 1 (1) 4 (15) <.001
Diaphragm paresis 6 (1) 2 (3) 3 (11) <.001
Chylothorax 13 (2) 6 (8) 5 (19) <.001
Arrest requiring CPR 3 (0.5) 3 (4) 0 (0) .009
Health care–associated infection 32 (5) 8 (10) 6 (22) .001
Need for blood transfusion 255 (43) 50 (65) 23 (85) <.001
Total packed RBCs transfused (mL/kg) 0 (0-14) 14 (0-20) 24 (14-45) <.001
RBCs transfused on POD 0 (mL/kg) 0 (0-10) 7 (0-15) 15 (4-30) <.001
Red blood cells transfused on POD 1 (mL/kg) 0 (0-0) 0 (0-9) 0 (0-14) <.001
Red blood cells transfused on POD 2 (mL/kg) 0 (0-0) 0 (0-0) 0 (0-15) <.001
Tracheostomy 3 (.5) 2 (2.6) 0 (0) .11
Noninvasive ventilation 81 (14) 17 (22) 12 (44) <.001
Central nervous system injury 13 (2) 5 (7) 4 (15) <.001
Reintubation 30 (5) 6 (8) 4 (15) .08
Unanticipated procedure (surgery or catheter)y 47 (8) 8 (10) 17 (63) <.001
Mediastinal reexploration 15 (3) 6 (8) 7 (26) <.001
Extracorporeal membrane oxygenation use 8 (1) 2 (3) 3 (11) .001
(Continued)
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No AKI (n ¼ 589) Stage 1 AKI (n ¼ 77) Stages 2 and 3 AKI (n ¼ 27) P value
Outcomes
Renal replacement therapy 2 (.3) 1 (1) 3 (11) <.001
ICU length of stay (d) 2 (1-4) 4 (2-8) 11 (6-17) <.001
ICU readmission 28 (5) 5 (7) 9 (33) <.001
Hospital length of stay (d) 6 (4-10) 9 (7-21) 33 (19-41) <.001
Death before discharge 5 (.8) 1 (1) 6 (22) <.001
Creatinine at discharge (mg/dL)z 0.3 (0.2-0.4) 0.3 (0.2-0.4) 0.3 (0.2-0.3) .17
Estimated creatinine clearance at discharge
(mL $ min1 $ 1.73 m2)x
113 (82-134) 97 (75-122) 107 (86-121) .18
Kidney disease at dischargex 4 (1) 2 (3) 0 (0) .38
Values are expressed as median (interquartile range) or n (%) as appropriate. Missing values: *(n ¼ 37), z(n ¼ 164), x(n ¼ 178). AKI, Acute kidney injury; RACHS, Risk Ad-
justment for Congenital Heart Surgery; CPB, cardiopulmonary bypass; CPR, cardiopulmonary resuscitation; RBCs, red blood cells; POD, postoperative day; ICU, intensive care
unit. yExcludes mediastinal reexploration.
Congenital Heart Disease Taylor et al
C
H
Dhospitalized at any given time than were those whose
renal function did not meet AKI criteria (AHR, 0.53;
95% CI, 0.33-0.87), but there was no detectable difference
in duration of hospitalization between those in whom
only mild disease developed and those whose renal
function did not meet AKI criteria. Postoperative AKI
was not associated with renal dysfunction at hospital
discharge, although the overall prevalence of the latter
was low (1%).
This study extends previous work describing the epide-
miology of CHS-AKI in children.8-13 The prevalence of
AKI was lower in the current study than in those
previously published (15% vs 36%-59%). There are
several possible explanations for this discrepancy. Subtle
variations in the AKI definitions used in the previous
studies might have led to higher prevalence estimates, that
is, pRIFLE without restriction to a specified postoperative
window in Zappitelli and associates,9 AKIN criteria within
7 days of surgery (vs 3 days) in Li and colleagues,11 and
AKIN criteria with urine output criteria in Blinder and co-
workers.8 Differing patient demographics may have con-
tributed to the discrepant findings. This is most apparent
in the study by Blinder and colleagues,8 who restricted their
study to infants who are at higher risk for a variety of ad-
verse outcomes, including AKI. Era effect, related to im-
provements in perioperative management stemming from
a heightened awareness of the potentially important conse-
quences of AKI, may also be contributing to the differences




Preop creatinine (mg/dL) 0.3 (0.2-0.4) 0.3 (0.2-0.4)
Postop max creatinine (mg/dL) 0.6 (0.5-0.7) 0.3 (0.3-0.4)
Max creatinine change (mg/dL) 0.2 (0.2-0.4) 0.0 (0.0-0.1)
Values are expressed as median (interquartile range). AKI, Acute kidney injury; Preop, pr
150 The Journal of Thoracic and Cardiovascular Surgunderwent surgery in a 6-year period preceding the current
study.
Despite the differences in overall prevalence, all 4
studies demonstrated that AKI was limited to mild
disease in the majority of those affected (57%-77%).
Each study attempted to identify risk factors for the devel-
opment of CHS-AKI. Strengthening their findings, we cor-
roborated the independent association between CHS-AKI
and longer cardiopulmonary bypass times and the lack
of an association between CHS-AKI and surgical
complexity (RACHS-1 category). Several other new poten-
tial CHS-AKI risk factors were identified in the present
study, including single ventricle physiology, prematurity,
peak 24-hour postoperative lactate concentration, and
previous heart surgery.
The effects of mild AKI on clinical outcomes after sur-
gery for congenital heart disease have not been studied
adequately, despite repeated observations that the major-
ity of AKI remains mild. Our finding that mild
CHS-AKI is not associated with hospital length of stay
corroborates those of Blinder and associates8 in their
study of infants undergoing heart surgery, but it contra-
dicts several studies of adults undergoing heart surgery.
The reasons underlying the apparent difference in epide-
miology of mild AKI after heart surgery between adults
and children are not clear, but several possible explana-
tions warrant consideration. Renal recovery potential after
acute insults such as cardiopulmonary bypass may be
more robust in children, rendering mild CHS-AKIlopment of AKI
2-10 y 10-18 y
AKI No AKI AKI No AKI
0.3 (0.3-0.3) 0.3 (0.3-0.4) 0.6 (0.4-0.8) 0.6 (0.5-0.7)
0.6 (0.5-0.6) 0.4 (0.3-0.4) 1.2 (1.0-1.5) 0.7 (0.6-0.8)
0.3 (0.2-0.4) 0.0 (0.0-0.1) 0.5 (0.4-0.5) 0.0 (0.0-0.1)
eoperative; max, maximum; Postop, Postoperative.
ery c July 2013
TABLE 3. Logistic regression analysis of AKI after surgery for
congenital heart disease (n ¼ 693)
Variable Adjusted OR 95% CI P value
Premature birth 2.4 1.01-5.8 .05
Single ventricle physiology 1.8 1.01-3.1 .05
Peak postoperative lactate
concentration (per 1 mmol/L)
1.3 1.01-1.5 <.001
RACHS-1 category 3 1.5 0.8-2.6 .18
CPB time (per min) 1.005 1.00-1.009 .04
Need for postop intervention 1.7 0.78-3.52 .19
Delayed sternal closure 0.7 0.3-1.7 .46
Postop blood transfusion quantity
(per 1 mL/kg)
1.010 0.998-1.023 .10
Preop polycythemia 1.2 0.7-2.0 .56
Previous heart surgery 1.9 1.1-3.3 .03
AKI, Acute kidney injury; OR, odds ratio; CI, confidence interval; RACHS, Risk Ad-
justment for Congenital Heart Surgery; CPB, cardiopulmonary bypass; postop, post-
operative; preop, preoperative.
TABLE 4. Proportional hazards model of hospital length of stay: The
independent effect of AKI (n ¼ 693)
Variable AHR* 95% CI P value
Age at surgery (per mo) 1.002 1.001-1.003 .006
Premature birth 0.63 0.44-0.91 .01
Preop mechanical ventilation 0.61 0.46-0.81 .001
CNS injury 0.51 0.28-0.92 .03
Necrotizing enterocolitis 0.36 0.16-0.78 .009
Diaphragm paresis 1.16 0.59-2.26 .67
Chylothorax 0.70 0.43-1.13 .14
Heart block 0.65 0.45-0.94 .02
Arrhythmia 0.76 0.61-0.95 .02
Single ventricle 0.68 0.53-0.87 .002
Tracheostomy 0.49 0.19-1.24 .13
Noninvasive ventilation 0.63 0.49-0.82 .001
Reintubation 0.69 0.47-1.03 .07
Postop catheterization or surgery 0.46 0.34-0.63 <.001
Delayed sternal closure 0.78 0.55-1.12 .18
Reexploration 0.81 0.48-1.36 .42
Polycythemia 1.02 0.86-1.21 .80
CPR 2.10 0.85-5.21 .1
Health care–associated infection 0.37 0.25-0.53 <.001
Peak lactate (per 1 mmol/L) 0.90 0.85-0.95 <.001
CPB time 1.29 0.93-1.78 .12
RACHS-1 category <.001
Category 1 1.00 (reference)
Category 2 0.40 0.30-0.53 <.001
Category 3 0.26 0.19-0.36 <.001
Category 4 0.24 0.16-0.35 <.001
Category 6 0.33 0.18-0.62 .001
ECMO 0.93 0.43-2.03 .85
ICU readmission 0.38 0.26-0.54 <.001
Blood transfusion 0.68 0.57-0.81 <.001
AKI stage .02
Absent 1.00 (reference)
Stage 1 0.85 0.66-1.10 .22
Stages 2 and 3 0.53 0.33-0.87 .01
Values are expressed as median (interquartile range) or n (%) as appropriate. AKI,
Acute kidney injury; AHR, adjusted hazard ratio; CI, confidence interval; Preop, pre-
operative; CNS, central nervous system; Postop, postoperative; CPR, cardiopulmo-
nary resuscitation; CPB, cardiopulmonary bypass; RACHS, Risk Adjustment for
Congenital Heart Surgery; ECMO, extracorporeal membrane oxygenation ICU, in-
tensive care unit. *A hazard ratio of less than 1 indicates a greater likelihood of re-
maining hospitalized on any given day.
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Dirrelevant with respect to outcomes.3,20,21 This possibility
is bolstered by our observation that those children in
whom CHS-AKI developed were no more likely to be
discharged from the hospitalwith renal dysfunction that those
who did meet AKI criteria. Alternatively, the existing
definitions of AKI may be inadequate to accurately define
a biologically relevant deterioration in renal function in
children.16,19 ‘‘Normal’’ serum creatinine ranges in children
(with the exception of newborns) are lower than in
adults, related to a higher glomerular filtration rate. The
combination of lower baseline serum creatinine values,
a definition of AKI based on percentage change in
creatinine, and the inherent analytical error in creatinine
testing may lead to misclassification of children without
biologically significant kidney injury as having stage 1
AKI, thereby suppressing the effect of real, but mild AKI
on outcomes.22
Several important limitations should be considered when
interpreting the results of this study. First, there is the pos-
sibility that patient selection bias, related to the exclusion of
patients secondary to missing data, affected the results of
the study. However the number of such patients was small.
Second, retrospective studies alone cannot prove causality,
that is, moderate to severe AKI may be associated with, but
not cause, prolongation of hospital length of stay. Third, the
updated Schwartz formula was used to calculate estimated
creatinine clearance and determine the presence of renal
dysfunction before surgery and at discharge. Although the
Schwartz formula is known to overestimate the glomerular
filtration rate, for reasons of practicality and general con-
sensus, it remains the only common method for estimating
renal function in children. Fourth, there is a possibility that
confounders of the relationship between AKI and outcomes
were not considered. Fifth, given the low mortality rate, we
were unable to evaluate the association between CHS-AKI
and death.The Journal of Thoracic and CaThe findings of this study suggest that CHS-AKI may not
be as common as previously thought and that trials target-
ing reduction of CHS-AKI should focus on those who have,
or are likely to have, moderate to severe disease, inasmuch
as mild disease does not appear to have much of an effect
on outcomes. Further research, preferably a large, prospec-
tive, multicenter study, will be necessary to determine
which risk factors predispose children to moderate to se-
vere CHS-AKI and to determine whether CHS-AKI is asso-
ciated with other clinically relevant outcomes. An accurate
risk prediction model of CHS-AKI, ideally incorporating
diagnostic biomarker data, would then set an appropriate
stage for therapeutic trials targeting amelioration of AKIrdiovascular Surgery c Volume 146, Number 1 151
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Dwith the goal of improving the outcomes of children under-
going surgery for congenital heart disease.References
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